Sage Laboratories Inc
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: Sage Laboratories Inc stock price vs KSS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at KSS's multiple
Needs EPS (TTM).
Implied fair value · at Sage Laboratories Inc's multiple
Needs Sage Laboratories Inc P/E.
Engine logicSage Laboratories Incvalued onKSS’smultiple
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Sage Laboratories Inc Latest annual filing · KSS FY 2026 (ended Jan 31, 2026). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 61% equity / 39% debt · EV / Revenue 0.19x · EV / EBITDA 4.70x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SAGE LABORATORIES INC · implied price per share
Reporting currency could not be verified.
KOHL’S CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Sage Laboratories Inc · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
—
0.35x
Net debt / EBITDA
Leverage against operating earnings
—
1.21x
Cash and equivalents
Liquid reserves on the balance sheet
—
$674.00M
Total debt
Interest-bearing obligations outstanding
—
$1.44B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TJX COMPANIES INC /DE/
Sage Laboratories Inc vs TJX
ROSS STORES, INC.
Sage Laboratories Inc vs ROST
Concrete Pumping Holdings, Inc.
Sage Laboratories Inc vs BBCP
NORDSTROM INC
Sage Laboratories Inc vs JWN
Walmart Inc.
Sage Laboratories Inc vs WMT
COSTCO WHOLESALE CORP /NEW
Sage Laboratories Inc vs COST
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.